Skip to content

About us

eCounsel group

A boutique firm with unparalleled expertise in business and technology. We have good command of industrial ecology and legal practice, and have undertaken highly regarded cases. Because the small business scope, we pay more emphasis on effectiveness and efficiency, and choose clients with deliberation. The managing partner not only has extensive experiences in various legal issues more over than 20 years, but invests and manages several technology companies. In addition, he always checks each case rigorously. Clients’ business objectives are our primary focus. To achieve the same in the most cost-effective fashion trumps all seemingly sophisticated legal discussions.

Healthcare vs. Drug Price

2015 - 12 - 09

Media in Taiwan has been reporting that drug price investigations result in low drug prices and pharmaceutical companies threaten to leave Taiwan.


台灣諸多媒體,一面講因為藥價調查造成健保核價太低、一面說原廠藥要退出台灣,連續不間斷地放送國外藥廠勾結醫師所發表的業配新聞。

他們藉此恐嚇公眾,並灌輸有病也無藥可用的醫療困境。

健保在藥品這個問題上當然有大問題,我們也認為核價這件事情應該有更合理的彈性。但是,大家是否清楚,在台灣,醫師開處方箋過度浮濫(順應病人要求)、病人的部分負擔太輕(上限NT$200)、各醫療院所為相同病人開立重複藥物、病人持處方箋取藥後未服用而廢棄之比例過高等的情事,已經造成台灣健保藥費在健保總支出上占有25%的比例。

我們再看看這篇WSJ報導:

Specialty medications for ills such as cancer and multiple sclerosis are so pricey that despite making up only about 1% of prescription volume at the University of Minnesota, they account for 28% of its drug costs, said Kenneth Horstman, director of benefits and compensation. Pharmacy costs are about 17% of its health plan’s spending, up from less than 14% in 2013

明尼蘇達大學給其現任及退休教職員與家屬(約39,000人)的醫療保險中,支付癌症和多發性硬化症的藥,雖然僅占處方箋的1%,但卻拿走了28%的藥費。2013年,藥費占全部醫療開支的14%,到2014已經到了17%,而17%,已讓老美陷入困境。

Another increasingly common strategy is “step therapy,” which requires that patients to be treated with lower-cost drugs before the health plan will pay for a more expensive option. This year, about 69% of employers had step-therapy rules, compared with 56% in 2011…

藥價年成長幅度近10%,高於其他醫療支出之成長幅度一倍。因此,愈來愈多的美國醫保方案,要求採用漸進式治療,也就是只准醫生處方箋上先開低價藥(否則不准核銷),如果無效才能再開較貴的藥品。2011年時只有56%的雇主採用這種模式的醫保,今年,升到69%。http://www.wsj.com/articles/employers-battle-drug-costs-1450488416

當然,還有其他措施,比方說提高病人必須自付的藥費的部分負擔。明尼蘇達大學已將最高上限調到了USD75,等於台幣$2,400,是台灣健保藥費部分負擔的12倍。

藥價與醫療保險政策,不是僅需搞定藥廠金援就可輕易解套。

Recommended article 

Merger Is Not the Cure for Everything

With Taiwan’s technology firms’ performance worsen, business pundits often advocates for mergers between local manufacturers or suppliers. 宏達電斷尾求生 能否東山再起? 「……光是靠台灣市場是沒有辦法讓宏達電起死回生的。唯一的辦法,也是拯救台灣品牌的方式,就是讓目前台灣幾家主要的智慧型手機廠商進行整併,大家一起重新整合資源,才有機會讓台灣品牌衝出一條路。」 http://udn.com/news/story/6848/1135575 每次遇到台廠出大問題,就會有企管蒙古大夫跳出來,開出「與競爭對手或上下游產業鏈整併」的處方箋。我看說他們蒙古夫夫並不貼切;藥到命除,用劊子手形容還合適些。 hTC + Asus + Acer + … 這種招式,小學生都講得出來。但是會不會有用? Continue reading

Tough to Eradicate Faulty Construction Projects

Only when the earthquake strike, can we find out how prevalent crooked construction agencies are in Taiwan. Continue reading

Caught in the Middle : Korea's next Move Against U.S and China

Love it or hate it, just like U.S military’s global power projection, the rise of China is as much an issue that we can’t avoid. From our perspective, we hate Washington more than Beijing. But we…